BioSpace News Archive

Business

BioMarin Announces Record Fourth Quarter and Full Year 2022 Total Revenues Driven by Strong Global Demand for VOXZOGO® and Steady Growth of Enzyme Business

BioMarin Pharmaceutical Inc. announced financial results for the fourth quarter and full year ended December 31, 2022.

February 27, 2023
·
29 min read
Genetown

Ironwood Pharmaceuticals to Participate in Upcoming March 2023 Investor Conferences

Ironwood Pharmaceuticals, Inc., a GI-focused healthcare company, announced that management will participate in the following investor conferences.

February 27, 2023
·
1 min read
Business

CONMED Corporation Announces Quarterly Cash Dividend - February 27, 2023

CONMED Corporation announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on April 5, 2023, to all shareholders of record as of March 15, 2023.

February 27, 2023
·
2 min read
Biotech Bay

Jazz Pharmaceuticals to Participate in Upcoming March 2023 Investor Conferences

Jazz Pharmaceuticals plc announced that the Company will participate in the following upcoming investor conferences.

February 27, 2023
·
1 min read
Business

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial and Operational Results

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare disorders with high unmet need, today reported financial and operational results for the fourth quarter and year ended December 31, 2022.

February 27, 2023
·
16 min read
Biotech Beach

Illumina To Webcast Upcoming March 2023 Investor Conference

Illumina, Inc. announced that its executives will be speaking at the following investor conference.

February 27, 2023
·
1 min read